MENU
SPRBD
Stock ticker: OTC
PRICE
CHANGE
CAPITALIZATION
Spruce Biosciences (SPRBD) Ownership - Who owns Spruce Biosciences?
Spruce Biosciences Inc is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with unmet medical needs... Show more
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
4.95M
P/E Ratio
N/A
Total Cash
N/A
Projected Growth
N/A
Total Debt
1.82M
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
N/A
Total Debt/Equity
N/A
Revenue/Share
2.28 USD as % of share price
Fundamentals
SPRBD
Capitalization
4.95M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
N/A
Total Cash/Share
N/A
Total Debt
1.82M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
2.28%
Revenue
N/A
ROE
N/A
Book Value
13.2M
P/B Ratio
0.38
Cash Flow
N/A
Earnings
N/A
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
0
Current Ratio
2.60
Current Revenue Per Employee
33190.48
Dividends Per Share - Security
N/A
EBITDA
N/A
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
N/A
Shares Held By Institutions
N/A
Shares Outstanding - Current
563K
Total Liabilities
8.64M
Total Volume MTD
N/A
Value
1
Gain YTD
-72.095
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. SPRBD showed earnings on August 08, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information